1. Home
  2. CODA vs SNTI Comparison

CODA vs SNTI Comparison

Compare CODA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • SNTI
  • Stock Information
  • Founded
  • CODA 1994
  • SNTI 2016
  • Country
  • CODA United States
  • SNTI United States
  • Employees
  • CODA N/A
  • SNTI N/A
  • Industry
  • CODA Industrial Machinery/Components
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CODA Industrials
  • SNTI Health Care
  • Exchange
  • CODA Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • CODA 92.5M
  • SNTI 85.3M
  • IPO Year
  • CODA N/A
  • SNTI N/A
  • Fundamental
  • Price
  • CODA $6.94
  • SNTI $3.26
  • Analyst Decision
  • CODA Strong Buy
  • SNTI Strong Buy
  • Analyst Count
  • CODA 1
  • SNTI 1
  • Target Price
  • CODA $11.00
  • SNTI $12.00
  • AVG Volume (30 Days)
  • CODA 44.8K
  • SNTI 226.2K
  • Earning Date
  • CODA 06-11-2025
  • SNTI 05-06-2025
  • Dividend Yield
  • CODA N/A
  • SNTI N/A
  • EPS Growth
  • CODA 61.24
  • SNTI N/A
  • EPS
  • CODA 0.34
  • SNTI N/A
  • Revenue
  • CODA $21,064,685.00
  • SNTI N/A
  • Revenue This Year
  • CODA $11.64
  • SNTI N/A
  • Revenue Next Year
  • CODA $14.53
  • SNTI N/A
  • P/E Ratio
  • CODA $20.42
  • SNTI N/A
  • Revenue Growth
  • CODA 15.63
  • SNTI N/A
  • 52 Week Low
  • CODA $5.76
  • SNTI $1.52
  • 52 Week High
  • CODA $9.89
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • CODA 58.52
  • SNTI 44.18
  • Support Level
  • CODA $6.41
  • SNTI $3.10
  • Resistance Level
  • CODA $6.95
  • SNTI $3.47
  • Average True Range (ATR)
  • CODA 0.38
  • SNTI 0.42
  • MACD
  • CODA 0.05
  • SNTI -0.07
  • Stochastic Oscillator
  • CODA 78.78
  • SNTI 16.74

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: